These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20116749)
21. Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease. Doehner W; Haeusler KG; Endres M; Anker SD; MacNee W; Lainscak M Respir Med; 2011 Oct; 105 Suppl 1():S12-9. PubMed ID: 22015080 [TBL] [Abstract][Full Text] [Related]
22. Part I: Identifying chronic obstructive pulmonary disease in patients with respiratory symptoms. Sussman R Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S5-12. PubMed ID: 17925063 [TBL] [Abstract][Full Text] [Related]
23. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases. Weitzenblum E; Chaouat A; Canuet M; Kessler R Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085 [TBL] [Abstract][Full Text] [Related]
24. Inflammation in COPD: pathogenesis, local and systemic effects. Barbu C; Iordache M; Man MG Rom J Morphol Embryol; 2011; 52(1):21-7. PubMed ID: 21424028 [TBL] [Abstract][Full Text] [Related]
25. Systemic effects of COPD. Decramer M; De Benedetto F; Del Ponte A; Marinari S Respir Med; 2005 Dec; 99 Suppl B():S3-10. PubMed ID: 16219454 [TBL] [Abstract][Full Text] [Related]
26. [The effect of comorbidity on prognosis in patients with COPD]. Cilli A; Uslu A; Oğüş C; Ozdemir T Tuberk Toraks; 2004; 52(1):52-5. PubMed ID: 15143373 [TBL] [Abstract][Full Text] [Related]
27. The 2007 GOLD Guidelines: a comprehensive care framework. Gold PM Respir Care; 2009 Aug; 54(8):1040-9. PubMed ID: 19650945 [TBL] [Abstract][Full Text] [Related]
28. Should COPD patients be routinely evaluated for bone mineral density? Karadag F; Cildag O; Yurekli Y; Gurgey O J Bone Miner Metab; 2003; 21(4):242-6. PubMed ID: 12811630 [TBL] [Abstract][Full Text] [Related]
31. Systemic consequences of COPD. Tkác J; Man SF; Sin DD Ther Adv Respir Dis; 2007 Oct; 1(1):47-59. PubMed ID: 19124347 [TBL] [Abstract][Full Text] [Related]
32. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. van Gestel YR; Chonchol M; Hoeks SE; Welten GM; Stam H; Mertens FW; van Domburg RT; Poldermans D Nephrol Dial Transplant; 2009 Sep; 24(9):2763-7. PubMed ID: 19369691 [TBL] [Abstract][Full Text] [Related]
33. COPD management. Part I. Strategies for managing the burden of established COPD. Jenkins C Int J Tuberc Lung Dis; 2008 Jun; 12(6):586-94. PubMed ID: 18492322 [TBL] [Abstract][Full Text] [Related]
34. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Sinden NJ; Stockley RA Thorax; 2010 Oct; 65(10):930-6. PubMed ID: 20627907 [TBL] [Abstract][Full Text] [Related]
35. [Prognostic markers of COPD. Role of comorbidity]. Alvarez FV; Romero GP Arch Bronconeumol; 2009; 45 Suppl 4():2-7. PubMed ID: 20116742 [TBL] [Abstract][Full Text] [Related]
37. Coexistent chronic obstructive pulmonary disease and heart failure in the elderly. Padeletti M; Jelic S; LeJemtel TH Int J Cardiol; 2008 Apr; 125(2):209-15. PubMed ID: 18221802 [TBL] [Abstract][Full Text] [Related]
38. Genetic and biochemical markers of obstructive lung disease in the general population. Dahl M Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391 [TBL] [Abstract][Full Text] [Related]
39. Shortness of breath--is it chronic obstructive pulmonary disease? McDonald CF Aust Fam Physician; 2005 Jul; 34(7):541-5. PubMed ID: 15999164 [TBL] [Abstract][Full Text] [Related]
40. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. Le Jemtel TH; Padeletti M; Jelic S J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]